Exclusion criteria included any pharmacological treatment of the gastrointestinal tract, systemic antibiotics within the last 3 months, probiotics or low-FODMAP-diet within the last 3 weeks, vegan or vegetarian diet, regular use of analgesics, pregnancy, prior gastrointestinal surgery apart from appendectomy (16)
Regional Trends: North America is expected to retain a dominant share of the GLP-1 peptide synthesis CDMO market throughout the forecast period, supported by its well-established pharmaceutical manufacturing infrastructure, robust regulatory framework, and substantial clinical demand for GLP-1-based therapies
27 Few clinicians, including endocrinologists, will go outside ATA guidelines, even when patients fail to reach a euthyroid state
Moro T, Brightwell CR, Phalen DE, McKenna CF, Lane SJ, Porter C, Volpi E, Rasmussen BB, Fry CS